These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 9467211

  • 1. Toxic digoxin-drug interactions: the major role of renal P-glycoprotein.
    Koren G, Woodland C, Ito S.
    Vet Hum Toxicol; 1998 Feb; 40(1):45-6. PubMed ID: 9467211
    [Abstract] [Full Text] [Related]

  • 2. Role of P-glycoprotein in renal tubular secretion of digoxin in the isolated perfused rat kidney.
    Hori R, Okamura N, Aiba T, Tanigawara Y.
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1620-5. PubMed ID: 8103798
    [Abstract] [Full Text] [Related]

  • 3. From bench to bedside: utilization of an in vitro model to predict potential drug-drug interactions in the kidney: the digoxin-mifepristone example.
    Woodland C, Koren G, Ito S.
    J Clin Pharmacol; 2003 Jul; 43(7):743-50. PubMed ID: 12856388
    [Abstract] [Full Text] [Related]

  • 4. Renal interaction between itraconazole and cimetidine.
    Karyekar CS, Eddington ND, Briglia A, Gubbins PO, Dowling TC.
    J Clin Pharmacol; 2004 Aug; 44(8):919-27. PubMed ID: 15286096
    [Abstract] [Full Text] [Related]

  • 5. Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein.
    Wakasugi H, Yano I, Ito T, Hashida T, Futami T, Nohara R, Sasayama S, Inui K.
    Clin Pharmacol Ther; 1998 Jul; 64(1):123-8. PubMed ID: 9695727
    [Abstract] [Full Text] [Related]

  • 6. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1).
    Tanigawara Y, Okamura N, Hirai M, Yasuhara M, Ueda K, Kioka N, Komano T, Hori R.
    J Pharmacol Exp Ther; 1992 Nov; 263(2):840-5. PubMed ID: 1359120
    [Abstract] [Full Text] [Related]

  • 7. Characteristics of the digoxin-quinidine and digoxin-verapamil interactions in the rat kidney.
    Koren G, MacLeod SM.
    Res Commun Chem Pathol Pharmacol; 1984 Jul; 45(1):3-18. PubMed ID: 6473899
    [Abstract] [Full Text] [Related]

  • 8. Digoxin-cyclosporin A interaction: modulation of the multidrug transporter P-glycoprotein in the kidney.
    Okamura N, Hirai M, Tanigawara Y, Tanaka K, Yasuhara M, Ueda K, Komano T, Hori R.
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1614-9. PubMed ID: 8103797
    [Abstract] [Full Text] [Related]

  • 9. A model for the prediction of digoxin-drug interactions at the renal tubular cell level.
    Woodland C, Ito S, Koren G.
    Ther Drug Monit; 1998 Apr; 20(2):134-8. PubMed ID: 9558126
    [Abstract] [Full Text] [Related]

  • 10. Current status of cardiac glycoside drug interactions.
    Hooymans PM, Merkus FW.
    Clin Pharm; 1985 Apr; 4(4):404-13. PubMed ID: 2412751
    [Abstract] [Full Text] [Related]

  • 11. Coadministration of digoxin with itraconazole in renal transplant recipients.
    Mathis AS, Friedman GS.
    Am J Kidney Dis; 2001 Feb; 37(2):E18. PubMed ID: 11157404
    [Abstract] [Full Text] [Related]

  • 12. P-glycoprotein system as a determinant of drug interactions: the case of digoxin-verapamil.
    Verschraagen M, Koks CH, Schellens JH, Beijnen JH.
    Pharmacol Res; 1999 Oct; 40(4):301-6. PubMed ID: 10527640
    [Abstract] [Full Text] [Related]

  • 13. Effects of quinidine on the renal tubular and biliary transport of digoxin: in vivo and in vitro studies in the dog.
    Koren G, Klein J, Giesbrecht E, Ben Dayan R, Soldin S, Sellers E, MacLeod S, Silverman M.
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1193-8. PubMed ID: 3204514
    [Abstract] [Full Text] [Related]

  • 14. The mechanism of the verapamil-digoxin interaction in renal tubular cells (LLC-PK1).
    Ito S, Woodland C, Harper PA, Koren G.
    Life Sci; 1993 Dec; 53(24):PL399-403. PubMed ID: 8246676
    [Abstract] [Full Text] [Related]

  • 15. Cellular mechanisms of digoxin transport and toxic interactions in the kidney.
    Koren G, Klein J, MacLeod S, Silverman M.
    Vet Hum Toxicol; 1986 Dec; 28(6):549-52. PubMed ID: 3538641
    [Abstract] [Full Text] [Related]

  • 16. Estimation of the glomerular filtration rate from serum creatinine and cystatin C with regard to therapeutic digoxin monitoring.
    Garcia A, Hermida J, Tutor JC.
    J Clin Pharmacol; 2007 Nov; 47(11):1450-5. PubMed ID: 17698593
    [No Abstract] [Full Text] [Related]

  • 17. Development, validation and utility of an in vitro technique for assessment of potential clinical drug-drug interactions involving P-glycoprotein.
    Keogh JP, Kunta JR.
    Eur J Pharm Sci; 2006 Apr; 27(5):543-54. PubMed ID: 16406207
    [Abstract] [Full Text] [Related]

  • 18. Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers.
    Ding R, Tayrouz Y, Riedel KD, Burhenne J, Weiss J, Mikus G, Haefeli WE.
    Clin Pharmacol Ther; 2004 Jul; 76(1):73-84. PubMed ID: 15229466
    [Abstract] [Full Text] [Related]

  • 19. The effects of mannitol diuresis on digoxin and phenobarbital handling by the kidney: implications for tubular reabsorption and secretion of the cardiac glycoside.
    Koren G, Klein J, Bentur Y, Giesbrecht E.
    Clin Invest Med; 1989 Oct; 12(5):279-84. PubMed ID: 2513154
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of the intestinal digoxin absorption and exsorption by quinidine.
    Su SF, Huang JD.
    Drug Metab Dispos; 1996 Feb; 24(2):142-7. PubMed ID: 8742224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.